Jean-Marie Michot

Publications

Article dans une revue (15)

Multicenter Analysis of General presentations and Imaging features in Cerebral MUCORmycosis (MAGICMUCOR): towards different entities Clémentine de la Porte Des Vaux,Corentin Provost,Anne Coste,Raoul Herbrecht,Blandine Deniset al. Medical Mycology, 2026, 64, ⟨10.1093/mmy/myaf122⟩ Article dans une revue hal-05456570v1
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA Amira Marouf,Sammara Chaubard,Raphaël Liévin,Jean-Marie Michot,Nicolas Molinariet al. HemaSphere, 2025, 9 (1), pp.e70081. ⟨10.1002/hem3.70081⟩ Article dans une revue hal-04926143v1
Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome Marion Plaçais,Ariane Laparra,Alexandre Thibault Jacques Maria,Nora Kramkimel,Audrey Perretet al. American Journal of Hematology, 2024, 99 (7), pp.1427-1430. ⟨10.1002/ajh.27339⟩ Article dans une revue hal-04960905v1
Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial Julieta Rodriguez,Capucine Baldini,Arnaud Bayle,Arnaud Pages,François Xavier Danloset al. JCO precision oncology, 2024, 8, pp.e2300631. ⟨10.1200/PO.23.00631⟩ Article dans une revue inserm-04981546v1
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma Yuta Ito,Amira Marouf,Yasunori Kogure,Junji Koya,Raphaël Liévinet al. Cancer Research, 2024, 84 (13), pp.2181-2201. ⟨10.1158/0008-5472.CAN-24-0132⟩ Article dans une revue inserm-04773439v1
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series Cyrille Coustal,Juliette Vanoverschelde,Xavier Quantin,Candice Lesage,Jean-Marie Michotet al. Journal for Immunotherapy of Cancer, 2023, 11 (5), pp.e004792. ⟨10.1136/jitc-2022-004792⟩ Article dans une revue hal-04116183v1
S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA Amira Marouf,Sammara Chaubard,J.M. Michot,Julien Rossignol,Camille Golfieret al. HemaSphere, 2023, Hemasphere, 7 (S3), pp.e41118bf. ⟨10.1097/01.hs9.0000967816.41118.bf⟩ Article dans une revue hal-04406218v1
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial Vincent Camus,Aurélien Belot,Lucie Oberic,David Sibon,Hervé Ghesquièreset al. Blood Advances, 2022, 6 (24), pp.6169-6179. ⟨10.1182/bloodadvances.2022007609⟩ Article dans une revue hal-04946564v1
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review C. Corti,G. Antonarelli,F. Scotté,J.P. Spano,J. Barrièreet al. Annals of Oncology, 2022, 33 (2), pp.158-168. ⟨10.1016/j.annonc.2021.10.014⟩ Article dans une revue hal-03955867v1
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study Charlotte Cabanié,Samy Ammari,Sophie Hans,Cedric Pobel,Ariane Laparraet al. European Journal of Cancer, 2021, 156, pp.46-59. ⟨10.1016/j.ejca.2021.07.015⟩ Article dans une revue hal-04532592v1
Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit Adrien Joseph,Audrey Simonaggio,Annabelle Stoclin,Antoine Vieillard-Baron,Guillaume Geriet al. Annals of Intensive Care, 2020, 10 (1), ⟨10.1186/s13613-020-00761-w⟩ Article dans une revue hal-02996544v1
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study Guillaume Manson,Alexandre Thibault Jacques Maria,Florence Poizeau,François-Xavier Danlos,Marie Kostineet al. Journal for Immunotherapy of Cancer, 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩ Article dans une revue hal-02530293v1
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience Sylvain Besle,Emilien Schultz,Antoine Hollebecque,Andreea Varga,Capucine Baldiniet al. European Journal of Cancer, 2018, 98 (2), pp.17-22. ⟨10.1016/j.ejca.2018.04.019⟩ Article dans une revue hal-04508716v1
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1 Ahmed Mekki,Laurent Dercle,Philip Lichtenstein,Aurélien Marabelle,Jean-Marie Michotet al. European Journal of Cancer, 2018, 96, pp.91-104. ⟨10.1016/j.ejca.2018.03.006⟩ Article dans une revue istex hal-04534637v1
Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease Jean-Marie Michot,Françoise Driss,Corinne Guitton,Julia Moh Klaren,François Lefebvreet al. Transfusion, 2015, 55 (2), pp.357-363. ⟨10.1111/trf.12875⟩ Article dans une revue istex inserm-01995062v1

Communication dans un congrès (1)

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA Amira Marouf,Sammara Chaubard,Jean-Marie Michot,Raphaël Liévin,Julien Rossignolet al. 17th International Conference on Malignant Lymphoma,, Jun 2023, Lugano, Switzerland. pp.502-503, ⟨10.1002/hon.3164_369⟩ Communication dans un congrès hal-04406191v1